参考文献/References:
[1] Sanna V, Chamcheu JC, Pala N,et al. Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment[J].Int J Nanomedicine,2015,10:6835-6846. DOI:10.2147/IJN.S93752.
[2] Liu J, Lee J, Salazar Hernandez MA,et al. Treatment of obesity with celastrol[J].Cell,2015,161(5):999-1011. DOI:10.1016/j.cell.2015.05.011.
[3] Ma X, Xu L, Alberobello AT,et al. Celastrol protects against obesity and metabolic dysfunction through activation of a HSF1-PGC1α transcriptional axis[J].Cell Metab,2015,22(4):695-708. DOI:10.1016/j.cmet.2015.08.005.
[4] Grant CW, Moran-Paul CM, Duclos SK,et al. Testing agents for prevention or reversal of type 1 diabetes in rodents[J].PLoS One,2013,8(8):e72989. DOI:10.1371/journal.pone.0072989.
[5] Abu Bakar MH, Cheng KK, Sarmidi MR,et al. Celastrol protects against antimycin A-induced insulin resistance in human skeletal muscle cells[J].Molecules,2015,20(5):8242-8269. DOI:10.3390/molecules20058242.
[6] Singaraja RR, Van Eck M, Bissada N,et al. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo[J].Circulation,2006,114(12):1301-1309. DOI:10.1161/CIRCULATIONAHA.106.621433.
[7] Wang C, Shi C, Yang X,et al. Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism[J].Eur J Pharmacol,2014,744:52-58. DOI: 10.1016/j.ejphar.2014.09.043.
[8] Han LP, Li CJ, Sun B,et al. Protective effects of celastrol on diabetic liver injury via TLR4/MyD88/NF-κB signaling pathway in type 2 diabetic rats[J].J Diabetes Res,2016,2016:2641248. DOI:10.1155/2016/2641248.
[9] Yu X, Tao W, Jiang F,et al. Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1[J].Am J Hypertens,2010,23(8):895-903. DOI:10.1038/ajh.2010.75.
[10] Zhu F, Li C, Jin XP, et al. Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model[J].Int J Clin Exp Med,2014,7(7):1684-1691.
[11] Gu L, Bai W, Li S, et al. Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress[J].PLoS One,2013,8(6):e65477. DOI:10.1371/journal.pone.0065477.
[12] Lu C, Yu X, Zuo K, et al. Tripterine treatment improves endothelial progenitor cell function via integrin-linked kinase[J].Cell Physiol Biochem,2015,37(3):1089-1103. DOI:10.1159/000430234.
[13] Yang H, Chen D, Cui QC,et al. Celastrol, a triterpene extracted from the Chinese “Thunder of God Vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice[J].Cancer Res,2006,66(9):4758-4765.DOI:10.1159/000430234.
[14] Ju SM, Youn GS, Cho YS,et al.Celastrol ameliorates cytokine toxicity and pro-inflammatory immune responses bysuppressing NF-κB activation in RINm5F beta cells[J].BMB Rep,2015,48(3):172-177.
[15] Xu L, Spinas GA, Niessen M. ER stress in adipocytes inhibits insulin signaling, represses lipolysis, and alters the secretion of adipokines without inhibiting glucose transport[J].Horm Metab Res,2010,42(9):643-651. DOI:10.1055/s-0030-1255034.
[16] Wang H, Garzon R, Sun H,et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma[J].Cancer Cell,2008,14(5):369-381. DOI: 10.1016/j.ccr.2008.10.006.
[17] Wang CX, Zhao AH. Leptin receptor overlapping transcript(LepROT)gene participates in insulin pathway through FoxO[J].Gene,2016,587(1):64-69. DOI: 10.1016/j.gene.2016.04.036.
[18] Platt TL, Beckett TL, Kohler K,et al. Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease[J].Neuroscience,2016,315:162-174. DOI:10.1016/j.neuroscience.2015.12.011.
[19] Mancour LV, Daghestani HN, Dutta S,et al. Ligand-induced architecture of the leptin receptor signaling complex[J].Mol Cell,2012,48(4):655-661. DOI:10.1016/j.molcel.2012.09.003.
[20] Ozcan L, Ergin AS, Lu A,et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance[J].Cell Metab,2009,9(1):35-51. DOI:10.1016/j.cmet.2008.12.004.
[21] Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism[J].Endocr Rev,2006,27(7):728-735. DOI:10.1210/er.2006-0037.
[22] Westerheide SD, Bosman JD, Mbadugha BN,et al. Celastrols as inducers of the heat shock response and cytoprotection[J].J Biol Chem,2004,279(53):56053-56060.DOI:10.1074/jbc.M409267200.
[23] Cullen KE, Sarge KD. Characterization of hypothermia-induced cellular stress response in mouse tissues[J].J Biol Chem,1997,272(3):1742-1746.
[24] Rosen ED, Sarraf P, Troy AE,et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro[J].Mol Cell,1999,4(4):611-617.
[25] Choi SK, Park S, Jang S,et al. Cascade regulation of PPARγ(2)and C/EBPα signaling pathways by celastrol impairs adipocyte differentiation and stimulates lipolysis in 3T3-L1 adipocytes[J].Metabolism,2016,65(5):646-654. DOI:10.1016/j.metabol.2016.01.009.
[26] Zhang D, Xu L, Cao F,et al. Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way[J].Cell Stress Chaperones,2010,15(6):939-946. DOI: 10.1007/s12192-010-0202-1.
[27] Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis[J].Fibrogenesis Tissue Repair,2010,3:21. DOI: 10.1186/1755-1536-3-21.
[28] Lee JK, Kim SY, Kim YS,et al. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin[J].Biochem Pharmacol,2009,77(8):1391-1400. DOI:10.1016/j.bcp.2009.01.009.
[29] Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response[J].Nature,2000,406(6797):782-787. DOI:10.1038/35021228.
[30] Asaoka Y, Nishina H. Diverse physiological functions of MKK4 and MKK7 during early embryogenesis[J].J Biochem,2010,148(4):393-401. DOI:10.1093/jb/mvq098.
[31] Baeuerle PA, Baltimore D. NF-kappa B: ten years after[J].Cell,1996,87(1):13-20.
[32] Lu Y, Ma Z, Zhang Z,et al. Yin Yang 1 promotes hepatic steatosis through repression of farnesoid X receptor in obese mice[J].Gut,2014,63(1):170-178. DOI: 10.1136/gutjnl-2012-303150.
[33] Nabekura T, Hiroi T, Kawasaki T,et al. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein[J].Biomed Pharmacother,2015,70:140-145. DOI:10.1016/j.biopha.2015.01.007.
[34] Carmiel-Haggai M, Cederbaum AI, Nieto N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats[J].FASEB J,2005,19(1):136-138.DOI:10.1096/fj.04-2291fje.
相似文献/References:
[1]曹琳,杨昱,刘超.减重手术对多囊卵巢综合征的治疗作用[J].国际内分泌代谢杂志,2014,(06):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
Cao Lin,Yang Yu,Liu Chao..Therapeutic effects of bariatric surgery on polycystic ovary syndrome[J].International Journal of Endocrinology and Metabolism,2014,(04):415.[doi:10.3760/cma.j.issn.1673-4157.2014.06.015]
[2]杨雪,时立新,张巧,等.中老年人群25-羟维生素D3与代谢综合征的
相关性分析[J].国际内分泌代谢杂志,2014,(05):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
Yang Xue*,Shi Lixin,Zhang Qiao,et al.Association between 25-hydroxyvitamin D3 and metabolic syndrome in middle-aged and elderly population[J].International Journal of Endocrinology and Metabolism,2014,(04):289.[doi:10.3760/cma.j.issn.1673-4157.2014.05.001]
[3]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(04):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[4]严克敏,朱惠娟,龚凤英.雷公藤红素:一种潜在的治疗肥胖症的新药物[J].国际内分泌代谢杂志,2017,37(01):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
Yan Kemin,Zhu Huijuan,Gong Fengying..Celastrol:a potential and novel drug for obesity[J].International Journal of Endocrinology and Metabolism,2017,37(04):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
[5]王雪姣,丁晓颖,彭永德.短链脂肪酸在2型糖尿病发病机制中的作用[J].国际内分泌代谢杂志,2017,37(04):270.
Wang Xuejiao,Ding Xiaoying,Peng Yongde..The role of short chain fatty acids in the pathogenesis of type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(04):270.
[6]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群
糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(04):298.
[7]谢幸 陈树春 朱海娇 刘阳 王幸.蛙皮素样受体亚型-3与代谢综合征[J].国际内分泌代谢杂志,2018,38(03):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
Xie Xing*,Chen Shuchun,Zhu Haijiao,et al.Bombesin receptor subtype-3 and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(04):176.[doi:10.3760/cma.j.issn.1673-4157.2018.03.008]
[8]聂秀玲.长期果糖摄入与代谢综合征[J].国际内分泌代谢杂志,2018,38(05):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
Nie Xiuling.Chronic fructose intake and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2018,38(04):339.[doi:10.3760/cma.j.issn.1673-4157.2018.05.014]
[9]肖扬 徐书杭 黄华英 郭玲 吕文君 冯宁霞 汪奇峰 茅晓东 陈国芳 刘超.常州地区青少年人群不同代谢综合征诊断标准的比较研究[J].国际内分泌代谢杂志,2020,40(01):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
Xiao Yang,Xu Shuhang,Huang Huaying,et al.A comparative study of the different diagnostic criteria for metabolic syndrome among adolescents in Changzhou area[J].International Journal of Endocrinology and Metabolism,2020,40(04):1.[doi:10.3760/cma.j.issn.1673-4157.2020.01.001]
[10]王应昉 曹璐 陈凤 许帅 陈风 郭妍 王岩 王涤非.社区老年居民握力体重指数与代谢综合征的相关性[J].国际内分泌代谢杂志,2020,40(01):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]
Wang Yingfang,Cao Lu,Chen Feng,et al.Relationship between handgrip strength body mass index and metabolic syndrome in community elderly residents[J].International Journal of Endocrinology and Metabolism,2020,40(04):5.[doi:10.3760/cma.j.issn.1673-4157.2020.01.002]